HUMANISIERTE ANTIKÖRPER GEGEN AMYLOID BETA

Patent europeic · EP2170389 · En vigur

Inscripziun en il register

Numer da publicaziun
EP2170389
Numer da la dumonda
EP08768371
Gener
Patent europeic cun effect per la Svizra ed il Liechtenstein
Status
En vigur
Scrittira da patent
Concedì
Annunzià
12-06-2008
Publitgà
07-04-2010
Concedì
29-10-2014
La protecziun finescha il pli tard
11-06-2028
Proxima taxa annuala scadenta
30-06-2026
Classas IPC
A61K 39/395 (2006.01)
A61P 25/28 (2006.01)
C07K 16/18 (2006.01)
Prioritad
US 943509 P 12.06.2007
Dumonda PCT
PCT/US2008/007318 12.06.2008
Publicaziun PCT
WO2008/156622 24.12.2008
Lingua da l’annunzia
englais
Funtauna
Swissreg

Istorgia

Quai che l’Institut federal da la proprietad intellectuala ha publitgà davart quest titel, il pli nov l’emprim.

  1. 01-07-2025

    Midada

    Published in Swissreg on 01.07.2025

  2. 01-07-2024

    Midada

    Published in Swissreg on 01.07.2024

  3. 01-07-2023

    Midada

    Published in Swissreg on 01.07.2023

  4. 01-07-2022

    Midada

    Published in Swissreg on 01.07.2022

  5. 17-01-2015

    Represchentant inscrit

    Representative
    Kirker & Cie S.A., 122, rue de Genève, Case postale 90, 1226 Geneve-Thônex

    Published in Swissreg on 17.01.2015

  6. 29-10-2014

    Concedì

    Published in Swissreg on 29.10.2014

Partidas

Il register numna mintga partida cun num ed adressa. In possessur u in represchentant vegn collià cun in’organisaziun, sch’exact ina unitad giuridica dal register da commerzi porta ses num; la via d’ina partida betg enconuschida uschia na vegn betg mussada qua.